Gut Microbiome-Mediated Neuroprotective Effect of the Mediterranean Diet: A Narrative Review of Cognitive Aging, Alzheimer’s Disease, and Parkinson’s Disease
Authors:
- Kundun KamalakarKKKundun Kamalakar
- Christa AkereleCAChrista Akerele
- Ezequiel LafontELEzequiel Lafont
- Lauren R. KoralnikLKLauren R. Koralnik
- Caitlin GilmanCGCaitlin Gilman
- Jose Clemente LitranJLJose Clemente Litran
- Jakleen LeeJLJakleen Lee
- Jessica Robinson-PappJRJessica Robinson-Papp
- Dolores MalaspinaDMDolores Malaspina
Open Access
Abstract
Background: Alzheimer’s disease (AD) and Parkinson’s disease (PD) are major neurodegenerative disorders for which disease-modifying therapies are limited. Increasingly, evidence suggests that diet influences neurodegenerative risk through interactions among the gut microbiome, immune system, and brain. The Mediterranean diet (MD) is associated with improved cognitive health, but the mechanisms underlying its potential neuroprotective effects remain incompletely understood. Objective: In this narrative review, evidence on microbiome-mediated mechanisms linking MD adherence to neuroprotection was synthesized, and how Mediterranean dietary components influence microbial ecology, metabolites, immune regulation, and neuroinflammation relevant to cognitive aging, AD, and PD was evaluated. Methods: Evidence from experimental, observational, and clinical studies was reviewed, focusing on microbial metabolites, intestinal barrier integrity, immune regulation, and inflammatory pathways. Discussion: Mediterranean dietary components, including fiber, polyphenols, whole grains, legumes, nuts, extra-virgin olive oil, and omega-3 fatty acids, may promote beneficial microbial communities and metabolite production. Short-chain fatty acids, secondary bile acids, indole derivatives, and phenolic metabolites may strengthen the intestinal and blood–brain barriers, regulate immune responses, and suppress neuroinflammation. Conversely, dysbiosis may increase intestinal permeability, lipopolysaccharide translocation, systemic inflammation, and microglial activation. However, evidence remains heterogeneous and largely observational or experimental. Conclusions: The MD may promote neuroprotection through interconnected diet–microbiome–immune pathways. Longitudinal and intervention studies integrating microbiome, metabolomic, inflammatory, neuroimaging, and cognitive measures are needed to establish causality and advance precision nutrition strategies to prevent neurodegenerative disease.Keywords
This publication has 142 references indexed in Scilit:
- Toxic Alpha-Synuclein and the Opening of the Gate: Blood–Brain Barrier Damage and Stepwise Leukocyte InfiltrationCellular and Molecular Neurobiology, 2026
- Synergistic Effects of Polyphenols and Gut Microbiota–Derived Metabolites on Inflammation and Metabolic Syndrome: A ReviewMolecular Nutrition & Food Research, 2026
- US Burden of Disorders Affecting the Nervous SystemJAMA Neurology, 2026
- Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and TherapyMedcomm, 2025
- Alpha-synuclein deposition patterns in Alzheimer’s disease: association with cortical amyloid beta and variable tau loadActa Neuropathologica, 2025
- Oxidative Stress: Signaling Pathways, Biological Functions, and DiseaseMedcomm, 2025
- Immunomodulatory Effects of Omega‐3 Fatty Acids: Mechanistic Insights and Health ImplicationsMolecular Nutrition & Food Research, 2025
- The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammationSeminars in Immunopathology, 2024
- Association of Mediterranean Diet With Cognitive Decline Among Diverse Hispanic or Latino Adults From the Hispanic Community Health Study/Study of LatinosJAMA Network Open, 2022
- Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axisCellular and Molecular Life Sciences, 2017